Researchers have developed a computational modeling platform that simulates tumor behavior and treatment response in liver ...
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...
Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...
Clinical data supporting the expanded approval come from the Phase I/II open-label multi-centre BUR-CL207 trial.
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary ...
6don MSN
No needles or downtime: why Rexonage is the collagen-boosting treatment to try for glowier skin
No pain, no gain? Not any more ...
FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Tract Bio ("Tract"), a biotechnology company discovering and developing novel therapies for cancer and inflammatory disease, today announced presentations at the American Association for Cancer ...
Once I’m lying on the treatment bed, under a fluffy towel, there’s a double cleanse, using Dr David Jack’s own products - ...
Elevara Medicines Appoints Biotech Veteran as CEO Founder and former CEO of Nasdaq listed IO Biotech, Dr Mai-Britt Zocca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results